Roles of NF-KB activation and peroxisome proliferator-activated teceptor famma inhibition in the effect of rifampin on inducible nitric oxide synthase transcription in human lung epithelial cells

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 4, 2009, Pages 1539-1545

  Yuhas, Yael ^a   Berent, Eva ^a   Cohen, Regev ^c   Ashkenazi, Shai ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN SUBUNIT; RIFAMPICIN; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; DNA; STAT1 PROTEIN, HUMAN; TUBERCULOSTATIC AGENT;

ARTICLE; CELL STIMULATION; CONCENTRATION RESPONSE; DNA BINDING; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIUM CELL; GENE CONTROL; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; LIPID METABOLISM; LUNG ALVEOLUS EPITHELIUM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; RECEPTOR BLOCKING; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION; CELL CULTURE; COLON; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; LUNG; METABOLISM; PHOSPHORYLATION;

ANTIBIOTICS, ANTITUBERCULAR; CELLS, CULTURED; COLON; DNA; EPITHELIAL CELLS; HUMANS; INTERFERON-GAMMA; LUNG; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; PPAR GAMMA; RIFAMPIN; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR;

EID: 65649135141     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00961-08     Document Type: Article

References (37)

1. Aflf, H., M. Benderdour, L. Mfuna-Endam, J. Martel-Pelletier, J. P. Pelle-tier, N. Duval, and H. Fahmi. 2007. Peroxisome proliferator-activated re-ceptor gamma 1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-lbeta in articular chondrocytes. Arthri-tis Res. Ther. 9:R31. (Pubitemid 46614012)
2. Aktan, F. 2004. iNOS-mediated nitric oxide production and its regulation. Life Sei. 75:639-653. (Pubitemid 38686696)
3. Blanchard, J.S. 1998. The ying and yang of rifampicin. Nat. Med. 4:92-96. (Pubitemid 28133068)
4. Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2:907-914. (Pubitemid 32976162)
5. Chen, C. W., Y. H. Chang, C. J. Tsi, and W. W. Lin. 2003. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the per-oxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/ STATl signaling pathway. J. Immunol. 171:979-988. (Pubitemid 36871413)
6. Crosby, M. B., J. Svenson, G. S. Gildeson, and T. K. Nowling. 2005. A novel PPAR response element in the murine iNOS promoter. MoI. Immunol. 42:1303-1310. (Pubitemid 40798946)
7. Ganster, R. W., B. S. Taylor, L. Shao, and D. Ã. Geller. 2001. Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-KB. Proc. Natl. Acad. Sei. USA 98:8638-8643. (Pubitemid 32678080)
8. Herr, A. S., G. M. Wochnik, M. C. Rosenhagen, F. Holsboer, and T. Rein. 2000. Rifampicin is not an activator of glucocorticoid receptor. MoI. Pharmacol. 57:732-737. (Pubitemid 30183713)
9. Jiang, C, T. Ting, and B. Seed. 1998. PPAR gamma agonists inhibit production of monocytic inflammatory cytokines. Nature 391:82-86. (Pubitemid 28079219)
10. Kim, M. S., T. R. Sweeney, J. K. Shigenaga, L. G. Chui, A. Moser, C. Grunfeld, and K. R. Feingold. 2007. Tumor necrosis factor and interleukin 1 decrease RXRalpha, FFARalpha, FFARgamma, LXRalpha, and the coactivators SRC-I, PGC-lalpha, and PGC-lbeta in liver cells. Metabolism 56:267-279. (Pubitemid 46084934)
11. Kleinert, H., A. Pautz, K. Linker, and P. M. Schwarz. 2004. Regulation of the expression of inducible nitric oxide synthase. Eur. J. Pharmacol. 500: 255-266. (Pubitemid 39304013)
12. Kleinen, H., P. M. Schwarz, and U. Forstermann. 2003. Regulation of the expression of inducible nitric oxide synthase. Biol. Chem. 384:1343-1364. (Pubitemid 37508640)
13. Kleine«, H., T. Wallerath, G. Fritz, I. Ihrig-Biedert, F. Rodriuez-Pascual, D. A. Geller, and U. Forstermann. 1998. Cytokine induction of NO synthase II in human DLD-I cells: roles of JAK-STAT, AF-I and NF-KB-signaling pathways. Br. J. Pharmacol. 125:193-201. (Pubitemid 28418772)
14. Kota, B. P., T. H. Huang, and B. D. Roufogalis. 2005. An overview on biological mechanisms of PPARs. Pharmacol. Res. 51:85-94. (Pubitemid 40040538)
15. Kristof, A. S., J. Marks-Konczalik, and J. Moss. 2001. Mitogen-activated protein kinases mediate activator protein-1-dependent human inducible ni-tric-oxide synthase promoter activation. J. Biol. Chem. 276:8445-8452. (Pubitemid 37385657)
16. Kwon, S., and S. C. George. 1999. Synergistic cytokine-induced nitric oxide production in human alveolar epithelial cells. Nitric Oxide 3:348-357. (Pubitemid 29406763)
17. Labro, M.-T. 2005. Anti-inflammatory activity of ansamycins. Expert Rev. Anti-Infect. Ther. 3:91-103. (Pubitemid 40277841)
18. Li, M., G. Pascual, and C. K. Glass. 2000. Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene. MoI. Cell. Biol. 20:4699-4707. (Pubitemid 30396117)
19. Méndez, M., and M. C. LaPointe. 2003. PPAR y inhibition of cyclooxygen-ase-2, PGE2 synthase, and inducible nitric oxide synthase in cardiac myo-cytes. Hypertension 42:844-850. (Pubitemid 37237334)
20. Mlambo, G., and L. B. Sigola. 2003. Rifampicin and dexamethasone have similar effects on macrophage phagocytosis of zymosan, but differ in their effects on nitrite and TNF-a production. Int. Immunopharmacol. 3:513-522. (Pubitemid 36419512)
21. Pahlevan, A. A., D. J. M. Wright, L. Bradley, C. Smith, and B. M. J. Foxwell. 2002. Potential of rifamides to inhibit TNF-induced NF-KB activation. J. Antimicrob. Chemother. 49:531-534. (Pubitemid 34223675)
22. Pasquale, T. R., and J. S. Tan. 2005. Nonantimicrobial effects of antibacterial agents. Clin. Infect. Dis. 40:127-135. (Pubitemid 40053470)
23. Pawliczak, R., C. Han, X. L. Huang, A. J. Demetris, J. H. Shelhamer, and T. Wu. 2002. 85-kDa cytosolic phospholipase A2 mediates peroxisome prolif-erator-activated receptor gamma activation in human lung epithelial cells. J. Biol. Chem. 36:33153-33163.
24. Ricote, M., A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass. 1998. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391:79-82. (Pubitemid 28079218)
25. Roy, S., S. Sharma, M. Sharma, R. Aggarwal, and M. Bose. 2004. Induction of nitric oxide release from the human alveolar epithelial cell line A549: an in vitro correlate of innate immune response to Mycobacterium tuberculosis. Immunology 112:471-480. (Pubitemid 38859526)
26. Sirsjo, A., A. C. Gidlof, A. Olsson, H. Torma, M. Ares, H. Kleinert, U. Forstermann, and G. K. Hansson. 2000. Retinoic acid inhibits nitric oxide synthase-2 expression through the retinoic acid receptor-a. Biochem. Bio-phys. Res. Commun. 270:846-851. (Pubitemid 30444795)
27. Sung, B., S. Park, B. P. Yu, and H. Y. Chung. 2006. Amelioration of age-related inflammation and oxidative stress by PPARgamma activator: sup-pression of NF-kappaB by 2,4-thizolidinedione. Exp. Gerontol. 41:590-599. (Pubitemid 43867228)
28. Tentori, L., G. Graziani, S. A. Porcelli, M. Sugita, M. B. Brenner, R. Madaio, E. Bonmassar, A. Giuliani, and A. Aquino. 1998. Rifampin increases cyto-kine-induced expression of the CDIb molecule in human peripheral blood monocytes. Antimicrob. Agents Chemother. 42:550-554. (Pubitemid 28114807)
29. Uchimura, K., M. Nakamuta, M. Enjoji, I. Takashi, R. Sugimoto, T. Muta, H. Iwamoto, and J. Nawata. 2001. Activation of retinoic X receptor and peroxisome proliferator-activated receptor--/ inhibits nitric oxide and tumor necrosis factor-a production in rat Kupffer cells. Hepatology 30:91-99. (Pubitemid 32016891)
30. Wang, A. C, X. Dai, B. Luu, and D. J. Conrad. 2001. Peroxisome prolifera-tor-activated receptor-gamma regulates airway epithelial cell activation. Am. J. Respir. Cell MoI. Biol. 24:688-693. (Pubitemid 32550590)
31. Werber, S., I. Shalit, I. Fabian, G. Steuer, T. Weiss, and H. Blau. 2005. Moxifloxacin inhibits cytokine-induced MAP kinase and NF-KB activation as well as nitric oxide synthesis in a human respiratory epithelial cell line. Antimicrob. Chemother. 55:293-300. (Pubitemid 40425451)
32. Yerramasetti, R., S. Gollapudi, and S. Gupta. 2002. Rifampicin inhibits CD95-mediated apoptosis of Jurkat T cells via glucocorticoid receptors by modifying the expression of molecules regulating apoptosis. J. Clin. Immu-nol. 22:37-45. (Pubitemid 34203127)
33. Yuhas, Y., E. Berent, H. Ovadia, I. Azoulay, and S. Ashkenazi. 2006. Ri-fampin augments cytokine-induced nitric oxide production in human alveo-lar epithelial cells. Antimicrob. Agents Chemother. 50:396-398. (Pubitemid 43042957)
34. Yuhas, Y., I. Azoulay-Alfaguter, E. Berent, and S. Ashkenazi. 2007. Rifampin inhibits prostaglandin E2 production and arachidonic acid release in human alveolar epithelial cells. Antimicrob. Agents Chemother. 51:4225-14130 (Pubitemid 350209869)
35. Zhou, M., R. Wu, W. Dong, A. Jacob, and P. Wang. 2008. Endotoxin down-regulates peroxisome proliferator-activated receptor-gamma via the increase in TNF-alpha release. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294: R84-R92.
36. Ziglam, H. M., D. R. Baldwin, I. Daniels, J. M. Andrews, and R. G. Finch. 2002. Rifampin concentrations in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum following a single 600 mg oral dose in patients undergoing fibre-optic bronchoscopy. J. Antimicrob. Chemother. 50:1011-1015. (Pubitemid 36032825)
37. Ziglam, H. M., I. Daniels, and R. G. Finch. 2004. Immunomodulating activity of rifampicin. J. Chemother. 16:357-361. (Pubitemid 39049886)